Home|Journals|Articles by Year|Audio Abstracts

Case Report

EJMCR. 2021; 5(8): 242-245

Guillain-Barre syndrome following COVID-19 infection in an elderly patient: a case report

Enkhmaa Luvsannyam, Arathi Jayaraman, Molly Sanjay Jain, Karan Sharma, Manoj Reddy Somagutta, Rathna Kumar Yallapragada.

Cited by 1 Articles

Background: Coronaviruses can affect multiple body systems and respiratory failure is the most common complication. Since the outbreak of coronavirus disease-2019 (COVID-19) in January 2020, the association between COVID-19 and Guillain-Barre syndrome (GBS) has been growing. GBS is known to be triggered by an antecedent infection, mostly viruses.
Case Presentation: We present a case of GBS in an 83-year-old female patient with a confirmed COVID-19 infection. The patient initially presented with fever, cough, and fatigue. She was treated with intravenous fluid and symptomatic treatment and discharged home after stabilization. Several weeks after her initial encounter, she experienced bilateral paresthesias as well as numbness and tingling in her lower extremities. The patientÂ’s neurological symptoms were not alleviated with standard intravenous immune globulin (IVIG) therapy; however, her symptoms significantly improved with subsequent plasmapheresis therapy.
Conclusion: Based on the emerging evidence of recent studies, there is a possible connection between COVID-19 and GBS. Clinicians should be aware of the neurological manifestations of COVID-19 infection. Early diagnosis and proper treatment of COVID-19 and its neurological symptoms are crucial to increase the chance of a successful recovery.

Key words: COVID-19, SARS-CoV-2, coronavirus, Guillain-Barre syndrome, acute inflammatory demyelinating polyneuropathy, case report.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.